The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
KG 4/2015: A randomized, controlled, multicenter, open-label phase III clinical trial of GV1001 with gemcitabine/capecitabine in previous untreated, eotaxin-high patients with advanced pancreatic ductal adenocarcinoma.
 
Jung Hyun Jo
No Relationships to Disclose
 
Yong-Tae Kim
No Relationships to Disclose
 
Ho Soon Choi
No Relationships to Disclose
 
Ho Gak Kim
No Relationships to Disclose
 
Hong Sik Lee
No Relationships to Disclose
 
Young Woo Choi
No Relationships to Disclose
 
Dong Uk Kim
No Relationships to Disclose
 
Kwang Hyuck Lee
No Relationships to Disclose
 
Eui Joo Kim
No Relationships to Disclose
 
Jeong Ho Han
No Relationships to Disclose
 
Seung Ok Lee
No Relationships to Disclose
 
Chang-Hwan Park
No Relationships to Disclose
 
Eun Kwang Choi
No Relationships to Disclose
 
Kyong Joo Lee
No Relationships to Disclose
 
Jae Yong Cho
No Relationships to Disclose
 
Woo Jin Lee
No Relationships to Disclose
 
Si Young Song
No Relationships to Disclose